Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 29,042 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disease;Neurological Clear all

Conditions: Dravet Syndrome
Interventions: zorevunersen, Sham Comparator; Drug · Other
Lead sponsor: Stoke Therapeutics, Inc; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 28
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 23 more

Conditions: Traumatic Brain Injury
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Insulin Sensitivity, Apathy
Interventions: Diet without soy, Diet with soy; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 50 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Facial Paralysis
Interventions: Psychosocial scales/questionnaires, 3D Facial Measurements; Other
Lead sponsor: Tufts University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Advanced Cancer, Pancreas Cancer, Pain
Interventions: Celiac Plexus Radiosurgery; Radiation
Lead sponsor: Dr. Yaacov Lawrence; Government
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: New York, New York • Columbus, Ohio

Conditions: Spinal Muscular Atrophy Type 3, Mitochondrial Myopathy
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 8 Years to 55 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Tinnitus
Interventions: Task-Based Functional Magnetic Resonance Imaging (fMRI); Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 60 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Optic Neuritis
Interventions: Privosegtor, Methylprednisolone, Placebo; Drug · Other
Lead sponsor: Oculis; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 4
States / cities: Livonia, Michigan • Charleston, South Carolina • Dallas, Texas + 1 more

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Perampanel, Placebo; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Traumatic Brain Injury
Interventions: Magnetic Resonance Imaging (MRI); Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 30 Years
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Neuroendocrine Tumors, Brain (Nervous System) Cancers, Colon/Rectal Cancer, Colon Cancer, Hepatobiliary Cancers, Hepatocellular Carcinoma (Hepatoma), Liver
Interventions: CT perfusion; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Stanford, California

Conditions: Advanced Solid Tumors
Interventions: EIK1004-001 (IMP1707-001); Drug
Lead sponsor: Eikon Therapeutics; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 6
States / cities: Denver, Colorado • Lake Mary, Florida • Boston, Massachusetts + 3 more

Conditions: Mucopolysaccharidosis Type II (MPS II)
Interventions: RGX-121; Genetic
Lead sponsor: REGENXBIO Inc.; Industry
Eligibility: 4 Months to 5 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 4
States / cities: Oakland, California • New Brunswick, New Jersey • Philadelphia, Pennsylvania + 1 more

Conditions: Malignant Primary Brain Tumors, Brain Metastases, Adult
Interventions: Pritumumab; Biological
Lead sponsor: Nascent Biotech; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Newport Beach, California • San Diego, California

Conditions: Amblyopia, Strabismus
Interventions: Pediatric Vision Scanner eye scan; Device
Lead sponsor: Rebiscan, Inc.; Industry
Eligibility: 6 Months to 6 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cardiomyopathy, Ischemic Heart Disease, Cardiac Amyloidosis
Interventions: Transthoracic Echocardiography (TTE); Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 10,040,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Stroke, Acute, TBI, Neuromuscular Diseases, Status Epilepticus, Coma, Cerebrovascular Disorders, Spinal Cord Injuries, Neurological Injury, Neurologic Injury
Interventions: Timing of placement; Other
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Glioblastoma Multiforme, High-Grade Glioma
Interventions: Gliadel wafer, Temozolomide, External Beam Radiation Therapy; Drug · Radiation
Lead sponsor: Methodist Healthcare - Memphis; Other
Eligibility: 18 Years to 72 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Insomnia
Interventions: Cognitive Behavioral Therapy for Insomnia, Deprescribing; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Amputation, Phantom Limb, Stump Pain
Interventions: perineural ropivacaine, normal saline (placebo); Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: San Diego, California

Conditions: Subarachnoid Hemorrhage, Intracranial Hemorrhage, Ischemic Strokes, Subdural Hematoma
Interventions: Glycerna, Jevity - Control Diet; Dietary Supplement
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 89 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Charcot-Marie-Tooth Disease, Hereditary Motor and Sensory Neuropathy IV
Interventions: Not listed
Lead sponsor: Neurogene Inc.; Industry
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Iowa City, Iowa • Dallas, Texas

Conditions: DM1, Myotonic Dystrophy, Myotonic Dystrophy 1, Myotonic Dystrophy Type 1, Myotonic Dystrophy Type-1, Myotonic Dystrophy, Type 1 (DM1), Myotonic Muscular Dystrophy
Interventions: Not listed
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Sleep Disturbance, Dementia
Interventions: Cognitive Behavioral Therapy for Insomnia; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Non-Interventional F-Two Isoprostane Trial (NIFTI)

Lifestyle Intervention for Improving Insulin Resistance and Concern for Health

3D Dynamic and Patient-Centered Outcomes of Facial Reanimation Surgery in Patients With Facial Paralysis

Celiac Plexus Radio-Surgery for Pain Management

Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

Exploration of Cortical Neural Network in Patients With Bothersome Tinnitus

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral Sclerosis

Longitudinal Study of Traumatic Brain Injury (TBI) in (University of Florida) UF Athletes

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)

Safety Study of Pritumumab in Brain Cancer

Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

Tracheostomy With Bedside Simultaneous Gastrostomy Vs Usual Care Tracheostomy And Delayed Gastrostomy Placement

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention

Naval Medical Center San Diego (NMCSD) - Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain

Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study

A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners